Tirzepatide bests insulin degludec for achieving blood sugar targets in type 2 diabetes: Lancet Medha Baranwal29 April 2022 9:00 AM ISTUSA: Once-weekly treatment with tirzepatide compared to insulin degludec led to superior glycemic control in patients with type 2 diabetes (T2D) on...
Tirzepatide plus insulin glargine improves blood sugar control in type 2 diabetes patients: SURPASS-5 trial Medha Baranwal12 Feb 2022 10:00 AM ISTUSA: The addition of once-weekly subcutaneous tirzepatide to insulin glargine may significantly improve blood sugar control versus placebo in patients...
Tirzepatide aids weight loss, improves metabolic health in type 2 diabetes: Study Medha Baranwal24 Nov 2021 9:00 AM ISTUSA: Tirzepatide use in patients with type 2 diabetes (T2D) positively impacts metabolic profile that can only be partially attributed to weight loss,...
Tirzepatide helps lower body weight, cardiovascular risk in diabetics Dr. Nandita Mohan28 Oct 2021 3:47 PM ISTTirzepatide is a dual Glucose-dependent Insulinotropic Polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is under...
Medical Bulletin 26/October/2021 Dr. Nandita Mohan26 Oct 2021 4:31 PM ISTHere are the Top Medical Stories of the dayShockwave therapy- treatment for chronic prostatitisExtracorporeal shock wave therapy (ESWT) is an...
Tirzepatide bests insulin glargine in lowering A1C, body weight and CV risk in diabetics: Lancet MD Editorial Team21 Oct 2021 10:15 AM ISTTirzepatide is a dual Glucose-dependent Insulinotropic Polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is under...
Tirzepatide Improves CVD Risk Biomarkers in Patients With diabetes: Study Dr. Shravani Dali12 Oct 2021 9:30 AM ISTTirzepatide use is associated with a reduction in several biomarkers associated with cardiovascular risk, suggests a study published in the...
Tirzepatide tied to robust liver and abdomen fat reduction compared to insulin degludec Dr Kartikeya Kohli2 Oct 2021 9:00 AM ISTINDIANAPOLIS-- Tirzepatide use was associated with greater improvements in liver fat content and abdominal adipose tissue compared to titrated...
Tirzepatide bests insulin degludec for reducing blood sugar and weight in T2DM: Lancet Medha Baranwal19 Aug 2021 9:00 AM ISTSpain: Once-weekly subcutaneous injection of tirzepatide (5, 10, and 15 mg) is superior to once-daily subcutaneous injection of titrated insulin...
Tirzepatide provides significant blood sugar and weight reduction in diabetics: SURPASS Trial Hina Zahid14 July 2021 11:45 AM ISTTirzepatide is delivering unprecedented results that could help millions of people with type 2 diabetes and their health care providers reach A1C and...
Tirzepatide bests semaglutide for blood sugar and weight control in diabetics: SURPASS-2 Medha Baranwal28 Jun 2021 10:21 AM ISTUSA: Tirzepatide showed superior management of blood sugar levels and weight loss compared to semaglutide in type 2 diabetes patients receiving...
Tirzepatide superior to insulin glargine for reducing weight and blood sugar: SURPASS-4 trial Medha Baranwal9 Jun 2021 11:00 AM ISTDelhi: The investigational diabetes drug tirzepatide led to superior blood sugar and body weight reductions than insulin glargine in patients with...
